Alzheimer; News from the web:

Dec 10 (Reuters) – Merck & Co said it will begin two late-stage trials of its experimental Alzheimer’s drug, one of the industry’s best hopes for slowing the memory-robbing disease, after an independent monitoring board reviewed its safety and recommended that more patients be recruited for studies.

Read all about it HERE